Article Text
Best practice
Management of convulsive status epilepticus in children
Statistics from Altmetric.com
Footnotes
Competing interests: Rod Scott is advising a pharmaceutical company about the licensing of buccal midazolam for the emergency treatment of seizures. If the licence is granted, his employing institution will gain financially, but he will not receive any personal benefit. None of the other authors have a conflict of interest.
Funding: This work was undertaken at GOSH/UCL Institute of Child Health which received a proportion of funding from the Department of Health’s NIHR Biomedical Research Centres funding scheme. The Centre for Paediatric Epidemiology and Biostatistics also benefits from funding support from the Medical Research Council in its capacity as the MRC Centre of Epidemiology for Child Health.